<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920121-0003</DOCNO><DOCID>920121-0003.</DOCID><HL>   Business Brief -- Corning Inc.:   Net Income Advances 15%,   Despite $8.2 Million Charge</HL><DATE>01/21/92</DATE><SO>WALL STREET JOURNAL (J), PAGE B6</SO><CO>   GLW</CO><MS>TECHNOLOGY (TEC)</MS><IN>DIVERSIFIED TECHNOLOGY (DTC)EARNINGS (ERN)</IN><NS>EARNINGS (ERN)</NS><RE>NORTH AMERICA (NME)NEW YORK (NY)UNITED STATES (US)</RE><LP>   Corning Inc. posted a 15% increase in fourth-quarterearnings, despite an $8.2 million charge associated with itsjoint venture that makes breast implants.   In the quarter, the Corning, N.Y., company earned $85.6million, or 45 cents a share, compared with year-ago net of$74.3 million, or 40 cents a share. Sales rose 6.9% to $826.3million.</LP><TEXT>   In New York Stock Exchange composite trading yesterday,Corning fell $4.75 to $65.25.   The results were led by sales gains in its laboratoryservices segment and in its optical fiber and cable business.   Corning posted nonoperating gains of $8.3 million,including a $5.3 million gain on the sale of less than a 10%interest in Corning Japan K.K. to Japanese investors.Yesterday, Corning announced the completion of that sale.   Offsetting those gains was the $8.2 million charge thatreflects Corning's share of a previously announcedfourth-quarter charge of $25 million by Dow Corning Corp. DowCorning, a joint venture of Dow Chemical Co. and Corning,last week halted sales of its breast implants after the Foodand Drug Administration called for a moratorium on the use ofimplants containing silicone gel, saying there isn't enoughevidence to prove their safety.</TEXT></DOC>